Institutional Subscriptions   Individual Subscriptions 
Editors/Authors   Librarians   Newsletter   Site Tour   A-Z Index   About   Contact Us   Help 
Log In | Log In via Athens
Disable Autosuggest
The Rational Clinical Examination
David L. Simel, Drummond Rennie
David L. Simel, James M. Grichnik, Reviewed by John D. Whited
Table 29-8 Skin Type Risk Factors for Melanoma6

Topics Discussed: melanoma, practice guidelines

Excerpt: "The US Preventive Services Task Force found the benefits of screening for melanoma unproven.4 However, the recommendation addressed screening with a total body skin examination. The task force recommends that clinicians be aware of the ABCD criteria or rapidly changing lesions that become apparent for whatever reason and that lesions with 1 or more abnormalities be biopsied. The evidence report behind those recommendations did not address the accuracy of the individual criteria.4 Using the data of the US Preventive Services Task Force, the Canadian Task Force on Preventive Health concluded that the evidence is conflicting for the total body skin examination in the general population.5 The World Health Organization makes no specific recommendations on screening. They do suggest stratifying patients by risk factor. Patients with skin types I to II are at the highest risk of melanoma, types III to IV confer intermediate risk, and types V to VI have the lowest risk (see Table 29-8).6Dr Grichnik is a founder and major shareholder in Digital Derm, Inc (MoleMapCD; total body photography) and has consulting and grant support from Electro-Optical-Systems, Inc (Melafind; melanoma detection device)...."
Log in to read the full chapter:
Subscriber Log In
Forgot your username/password?
Get full access to JAMAevidence two ways:
Subscribe to JAMAevidence
JAMAevidence is a subscription-
based website dedicated to the learning, teaching, and practicing of evidence-based medicine.
Pay Per View
Timed access to all of JAMAevidence
24 hours for $34.95
48 hours for $54.95
Copyright © American Medical Association. All rights reserved.  |  JAMA  |  McGraw-Hill Global Education Holdings, LLC.
Privacy Notice. Any use is subject to the Terms of Use and Notice. Additional Credits and Copyright Information.
Your IP address is